DK1018018T3 - Fremgangsmåde til diagnosticering - Google Patents

Fremgangsmåde til diagnosticering

Info

Publication number
DK1018018T3
DK1018018T3 DK98941151.7T DK98941151T DK1018018T3 DK 1018018 T3 DK1018018 T3 DK 1018018T3 DK 98941151 T DK98941151 T DK 98941151T DK 1018018 T3 DK1018018 T3 DK 1018018T3
Authority
DK
Denmark
Prior art keywords
predicting
development
lung damage
damage
diagnosing
Prior art date
Application number
DK98941151.7T
Other languages
English (en)
Inventor
Ian Ross Doyle
Andrew David Bersten
Terence Evan Nicholas
Original Assignee
Southern Medical Diagnostics Pty
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8999A external-priority patent/AUPO899997A0/en
Priority claimed from AUPP5062A external-priority patent/AUPP506298A0/en
Application filed by Southern Medical Diagnostics Pty filed Critical Southern Medical Diagnostics Pty
Application granted granted Critical
Publication of DK1018018T3 publication Critical patent/DK1018018T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Control Of Eletrric Generators (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Vehicle Body Suspensions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
DK98941151.7T 1997-09-05 1998-09-04 Fremgangsmåde til diagnosticering DK1018018T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8999A AUPO899997A0 (en) 1997-09-05 1997-09-05 A method of diagnosis
AUPP5062A AUPP506298A0 (en) 1998-08-04 1998-08-04 A method of diagnosis - II
PCT/AU1998/000723 WO1999013337A1 (en) 1997-09-05 1998-09-04 A method of diagnosis

Publications (1)

Publication Number Publication Date
DK1018018T3 true DK1018018T3 (da) 2010-11-15

Family

ID=25645598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98941151.7T DK1018018T3 (da) 1997-09-05 1998-09-04 Fremgangsmåde til diagnosticering

Country Status (10)

Country Link
US (1) US8097420B1 (da)
EP (1) EP1018018B1 (da)
JP (2) JP4584445B2 (da)
AT (1) ATE476662T1 (da)
CA (1) CA2303169C (da)
DE (1) DE69841804D1 (da)
DK (1) DK1018018T3 (da)
IL (3) IL134880A0 (da)
NZ (1) NZ503175A (da)
WO (1) WO1999013337A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2101496B1 (en) 1996-02-28 2013-01-23 Panasonic Corporation High-resolution optical disk for recording stereoscopic video, optical disk reproducing device and optical disk recording device
WO2004077056A1 (en) * 2003-02-27 2004-09-10 Lung Health Diagnostics Pty. Ltd. A method of diagnosis and agents useful for same
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
EP1845379A1 (en) * 2006-04-13 2007-10-17 F. Hoffmann-La Roche AG Means and methods for the differentiation of cardiac and pulmonary causes of shortness of breath
EP1882945A1 (en) 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath
EP2031397A1 (en) 2007-08-30 2009-03-04 F. Hoffmann-La Roche AG Surfactant proteins B and D in differentiating the causes of shortness of breath
CN101938939B (zh) * 2008-02-07 2014-11-26 皇家飞利浦电子股份有限公司 用于测量和预测患者呼吸稳定性的装置
WO2012130731A1 (en) 2011-03-25 2012-10-04 Roche Diagnostics Gmbh MEASUREMENT OF C-TERMINAL proSP-B
CN102552879B (zh) * 2012-03-15 2013-11-06 北京双鹤现代医药技术有限责任公司 肺表面活性提取物与肺表面活性物质相关蛋白a的组合物、制备方法及其制药用途
EP2650684A1 (en) 2012-04-10 2013-10-16 Roche Diagniostics GmbH Pro SP-B and NT-proBNP based diagnosis in patients with pneumonia
EP2615459A1 (en) 2012-04-27 2013-07-17 Roche Diagniostics GmbH proSP-B based diagnosis of distal airway involvement in asthma
EP2866033A1 (en) 2013-10-23 2015-04-29 Roche Diagniostics GmbH Differential diagnosis of acute dyspnea based on C-terminal proSP-B, KL-6 and BNP-type peptides
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
EP3287921B1 (en) * 2016-08-26 2020-11-04 Nxp B.V. Spoken pass-phrase suitability determination

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650147T2 (de) * 1985-05-31 1995-04-06 Teijin Ltd Verfahren zur bestimmung menschlicher lungenoberflächenaktiver substanz und reagenziensatz dazu.
KR920001533B1 (ko) 1987-09-01 1992-02-18 데이진 가부시끼가이샤 인간 폐표면 활성물질의 측정방법
JP2517696B2 (ja) * 1990-04-27 1996-07-24 帝人株式会社 肺疾患マ―カ―蛋白の測定法
ES2093778T3 (es) 1991-04-26 1997-01-01 Surface Active Ltd Nuevos anticuerpos y metodos para su uso.
US5670328A (en) 1992-06-09 1997-09-23 Yamasa Corporation Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof
DE69333283T2 (de) * 1992-06-09 2004-08-26 Yamasa Corp., Chishi Lungenkrankheiten screening durch messung der HUMANES OBERFLÄCHENAKTIVES APOPROTEIN D DER LUNGE
ATE292800T1 (de) 1998-07-24 2005-04-15 Altana Pharma Ag Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof

Also Published As

Publication number Publication date
JP4584445B2 (ja) 2010-11-24
IL134880A (en) 2006-12-10
DE69841804D1 (de) 2010-09-16
EP1018018A1 (en) 2000-07-12
JP2010197405A (ja) 2010-09-09
HK1029622A1 (en) 2001-04-06
IL134880A0 (en) 2001-05-20
EP1018018B1 (en) 2010-08-04
JP2001516057A (ja) 2001-09-25
US8097420B1 (en) 2012-01-17
EP1018018A4 (en) 2004-12-22
NZ503175A (en) 2002-11-26
ATE476662T1 (de) 2010-08-15
CA2303169C (en) 2009-11-10
CA2303169A1 (en) 1999-03-18
WO1999013337A1 (en) 1999-03-18
IL172185A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
DK1018018T3 (da) Fremgangsmåde til diagnosticering
DK1328421T3 (da) Fremgangsmåde og apparat til vurdering og forbedring af en førers arbejdspræstation
FR2847267B1 (fr) Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2
EP1099102A4 (en) USE OF AN ARTIFICIAL OLFACTOMETRY FOR DETECTING THE LEVEL OF PRESENCE OF SUBSTANCES TO BE ANALYZED
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
DE60218863D1 (de) Herz-lungen-überwachungsgerät
DE69821931D1 (de) System zum genauen überwachen des kardiovaskulären zustandes eines lebewesens
DK0607225T3 (da) Apparat til bestemmelse af den operative effektivitet af et maskinværktøj og fremgangsmåde dertil.
NO20020837D0 (no) Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer
SE0101912D0 (sv) a method and an apparatus for measuring functional, residual capacity (FRC) and cardiac output (CO)
DK0939651T3 (da) Materialer og metoder ved diagnose og behandling af præeclapsia
NO941485L (no) Fremgangsmåte for in vivo måling av konsentrasjonen av NMR-påviselig xenobiotisk forbindelse
DE60322848D1 (de) System für kontinuierliche leistungstests
BR0207548A (pt) Método de controle de poeira automatizado
ATE272842T1 (de) Diagnose spongiformer encephalopathie
DK0647164T3 (da) Planhedsstyring ved båndvalsning
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
CA2091637A1 (en) Call Progress Monitoring
WO1998041238A3 (en) Methods and kits for treating and diagnosing leiomyomas
ES2187552T3 (es) Un sistema de medicion, principalmente ambulatoria, por medio de un electrodo.
DE69532611D1 (de) Mittel zur behandlung von autoimmunkrankheiten
NO20002176D0 (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
DE60127935D1 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie
DE60220185D1 (de) Screening-verfahren für substanzen zur behandlung von diabetes
KR880701886A (ko) 췌장효소원의 유리활성화 펩티드의 면역검정에 의한 질병의 진단, 위중도 예견, 및 모니터링